OOVA
Oova is a women's health technology company that offers at-home hormone monitoring kits and an AI-powered app to track fertility and perimenopause. The system measures luteinizing hormone (LH), E3G (an estrogen metabolite), and PdG (a progesterone metabolite) through urine tests, providing quantitative hormone levels and personalized insights. Oova aims to empower individuals by offering a data-driven approach to understanding their unique cycle patterns, predicting ovulation, and supporting informed decision-making for conception or navigating perimenopause. The company is backed by venture capital and trusted by over 100 clinics, emphasizing scientific expertise and innovative technology.
OOVA
Oova is a women's health technology company that offers at-home hormone monitoring kits and an AI-powered app to track fertility and perimenopause. The system measures luteinizing hormone (LH), E3G (an estrogen metabolite), and PdG (a progesterone metabolite) through urine tests, providing quantitative hormone levels and personalized insights. Oova aims to empower individuals by offering a data-driven approach to understanding their unique cycle patterns, predicting ovulation, and supporting informed decision-making for conception or navigating perimenopause. The company is backed by venture capital and trusted by over 100 clinics, emphasizing scientific expertise and innovative technology.
TL;DR
Product: At-home quantitative urine hormone tests (LH, E3G, PdG) plus an AI-powered smartphone app
Use cases: Fertility tracking, ovulation prediction, perimenopause mapping, hormone imbalance monitoring
Founding: Founded 2017 as a Mount Sinai spin-out
Funding: Venture-backed; Series A June 12, 2023 (lead: Spero Ventures)
Company Overview
Problem Domain
Women's health — fertility, ovulation prediction, perimenopause monitoring, and hormone-related condition tracking
Founded
2017
Industry
Femtech / Women's Health
Funding Track Record
1200000.00
Reported seed funding to support launch of Oova Kit
10300000.00
June 2023 round reported with additional named investors
Investor Signal
“Spero Ventures led Series A; other institutional and angel investors named across rounds (e.g., BBG Ventures, Virgin Group, Connecticut Innovations, Jefferson Health, Sara Blakely)”